Beginning with the royalties received from Harry Steenbock's vitamin D invention, WARF has set aside funds to build a perpetual investment portfolio to support, encourage and aid research at the University of Wisconsin. More recently, the investment portfolio also has supported scientific programs at the Morgridge Institute for Research, a biomedical research organization that works to solve major challenges to human health in collaboration with the university.
Through prudent management and oversight, WARF’s investment portfolio has grown to more than $2.6 billion (as of June 30, 2016).
The portfolio comprises restricted and unrestricted funds. Approximately 80% of the assets are unrestricted. Donor-directed funds are managed according to the wishes of the donor, while royalty funds are managed on behalf of the department from which the royalties were derived. WARF also manages funds on behalf of the Morgridge Institute for Research.
$2.67 Billion in Total Portfolio Assets
(as of June 30, 2016)